| 摘要 |
<p>The use of at least one first substance related to the growth hormone (GH) axis, and of at least one second substance, wherein said second substance upon administration to a patient leads to increased beta adrenergic receptor blockade, for the production of a pharmaceutical composition for the treatment of congestive heart failure (CHF) is disclosed. The use of said at least one first or second substance, respectively, for the production of a pharmaceutical composition for the treatment of congestive heart failure (CHF), intended for administration in combination with a pharmaceutical composition comprising said at least one second or first substance, respectively, is also disclosed. Also a method for treatment of congestive heart failure (CHF), wherein a pharmaceutically active amount of said at least one first substance is administered to a patient in combination with the administration to a patient of a pharmaceutically active amount of said at least one second substance is disclosed.</p> |
